Lisencu, L.A.; Roman, A.; Visan, S.; Bonci, E.-A.; Pașca, A.; Grigorescu, E.; Mustea, E.; Cismaru, A.; Irimie, A.; Lisencu, C.;
et al. The Role of miR-375-3p, miR-210-3p and Let-7e-5p in the Pathological Response of Breast Cancer Patients to Neoadjuvant Therapy. Medicina 2022, 58, 1494.
https://doi.org/10.3390/medicina58101494
AMA Style
Lisencu LA, Roman A, Visan S, Bonci E-A, Pașca A, Grigorescu E, Mustea E, Cismaru A, Irimie A, Lisencu C,
et al. The Role of miR-375-3p, miR-210-3p and Let-7e-5p in the Pathological Response of Breast Cancer Patients to Neoadjuvant Therapy. Medicina. 2022; 58(10):1494.
https://doi.org/10.3390/medicina58101494
Chicago/Turabian Style
Lisencu, Lorena Alexandra, Andrei Roman, Simona Visan, Eduard-Alexandru Bonci, Andrei Pașca, Emilia Grigorescu, Elena Mustea, Andrei Cismaru, Alexandru Irimie, Cosmin Lisencu,
and et al. 2022. "The Role of miR-375-3p, miR-210-3p and Let-7e-5p in the Pathological Response of Breast Cancer Patients to Neoadjuvant Therapy" Medicina 58, no. 10: 1494.
https://doi.org/10.3390/medicina58101494
APA Style
Lisencu, L. A., Roman, A., Visan, S., Bonci, E.-A., Pașca, A., Grigorescu, E., Mustea, E., Cismaru, A., Irimie, A., Lisencu, C., Balacescu, L., Balacescu, O., & Tudoran, O.
(2022). The Role of miR-375-3p, miR-210-3p and Let-7e-5p in the Pathological Response of Breast Cancer Patients to Neoadjuvant Therapy. Medicina, 58(10), 1494.
https://doi.org/10.3390/medicina58101494